First-in-human Study of OVM-200 as a Therapeutic Cancer Vaccine

Clinical trial NCT05104515 · RECRUITING

Trial details

NCT number: NCT05104515
Sponsor: Oxford Vacmedix UK Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Prostate Cancer Non Small Cell Lung Cancer Ovarian Cancer

Start date: 2021-11-01
Primary completion: 2025-11-30
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.